What is McKesson?
{{Infobox organization | name = McKesson Corporation | logo = McKesson logo.svg | image= McKesson Plaza east side 1.JPG | caption = McKesson Plaza at 1 Post Street in [[San Francisco]] | type = Public | headquarters = [[Irving, Texas]], United States | products = Pharmaceuticals Medical technology Health care services | key_people = Brian S. Tyler (CEO) }}McKesson is a multinational [[United States|American]] [[healthcare]] industry company. The company is from [[Texas]], and they are Number 8 on the [[Fortune 500]], with more than $214 billion in annual revenue.<ref>{{Cite web|last=Leggate|first=James|date=2020-07-22|title=What is McKesson?|url=https://www.foxbusiness.com/markets/what-is-mckesson|access-date=2023-12-15|website=FOXBusiness|language=en-US}}</ref> The company is named in a federal lawsuit for making profit from epidemic in the United States.<ref>{{Cite web|last=Leggate|first=James|date=2020-07-22|title=What is McKesson?|url=https://www.foxbusiness.com/markets/what-is-mckesson|access-date=2023-12-15|website=FOXBusiness|language=en-US}}</ref> McKesson's contributions to the U.S. government's [[COVID-19]] vaccine distribution efforts included serving as the centralized distributor for hundreds of millions of doses and assembling and distributing over 1 billion ancillary supply kits across the country.<ref>{{Cite web|title=Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution|url=https://www.biospace.com/article/operation-warp-speed-selects-mckesson-for-covid-19-vaccine-distribution/|access-date=2023-12-16|website=BioSpace|language=en-US}}</ref><ref>{{Cite news|title=McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS|pages=1-22|work=McKesson|url=https://s24.q4cdn.com/128197368/files/doc_financials/2022/q4/MCK-Q4-FY22-Earnings-Release_FINAL.pdf}}</ref> ==References== {{reflist}} [[Category:Healthcare companies of the United States]] [[Category:Companies based in Texas]] {{US-stub}}